Blue Matter Blog

Blue Matter “Breakfast Club” Meeting #5: Practical Implications of the COVID-19 Crisis for Biopharma
July 28, 2020

The Blue Matter Breakfast Club is an ongoing series of discussion forums (now virtual due to COVID-19), hosted by our team in Europe.  These forums are by invitation, bringing together leading executives from biopharma companies and other organizations to discuss critical business issues. The fifth Breakfast Club meeting took place on 8th July 2020.  The …

Blue Matter “Breakfast Club” Meeting #4: A Conversation with Dr. Thomas Lönngren, Former Exec. Dir. of the EMA
May 20, 2020

The Blue Matter Breakfast Club is an ongoing series of two-hour breakfast forums, hosted by our team in Europe.  These forums are by invitation, bringing together thought leaders and executives from biopharma companies and other organizations to discuss critical business issues. The fourth Breakfast Club meeting was a virtual event on 13th May 2020.  The guest …

The COVID-19 Challenge: How Pharma Can Adapt and Succeed in the Face of an Uncertain Future
March 31, 2020

Current Scenario: Challenges, Opportunities, and Critical Success Factors The current situation regarding COVID-19 is alarming.  At the time of publication, infection and death rates are continuing to rise rapidly in the United States, Spain, Switzerland, and many other European countries. In other countries like China, Italy, and Germany the situation appears to be resolving, but …